Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Solarea Bio Appoints Ilissa Larimore As Chief Commercial Officer

PRIVATEJun 26, 2024almost 2 years ago

Company

Solarea Bio

WalthamBiotechnology

Description

Solarea Bio announces the appointment of Ilissa Larimore as Chief Commercial Officer (CCO). Ilissa Larimore joins Solarea Bio with over 20 years of experience in consumer health, personalized wellness, and practitioner engagement to help individuals achieve optimal health. She will oversee all commercial activities, driving the strategy for sales, marketing, practitioner partnerships, and industry collaborations, with a focus on advancing new products to market utilizing Solarea's innovative technology platform.

Company Information

Company

Solarea Bio

Location

100 Beaver St

Waltham, Massachusetts, United States

About

Solaria Bio is a biotech company unlocking the power of the plant microbiome to advance human health. We translate discoveries in microbial science into clinically proven medical foods that address root biological drivers of disease. Our first product, Bōndia, is the world’s first plant-sourced synbiotic clinically proven to preserve bone density by working through the gut–bone axis. Developed using our proprietary Microscape Technology™, Bōndia represents a new, scientifically validated approach to managing bone loss by harnessing beneficial microbes naturally found on fruits and vegetables to restore gut balance, reduce inflammation, and preserve bone density. In a gold-standard, randomized, placebo-controlled clinical trial published in Osteoporosis International, Bōndia improved bone density by 85% in women with osteopenia. This is just the beginning. We’re building the world’s largest library of plant-derived microbes to address underserved inflammatory conditions — from osteopenia to rheumatoid arthritis. Our mission is to bridge cutting-edge microbiome research with everyday human health.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Solarea Bio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.